Sunnymeath Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$107K Sell
1,897
-3,144
-62% -$184K 0.15% 84
2016
Q3
$149K Buy
5,041
+3,144
+166% +$184K 0.33% 70
2016
Q2
$105K Hold
1,897
0.15% 82
2016
Q1
$96K Buy
+1,897
New +$92.9K 0.15% 78

Other funds holding MRK

Sunnymeath Asset Management's MRK Position: Q4 2016 in Review

Sunnymeath Asset Management reduced its Merck (MRK) stake by 62% in Q4 2016, selling an estimated $184K and leaving 1,897 shares worth $107K. The position accounts for 0.15% of the portfolio, ranked #84.

Sunnymeath Asset Management first reported a position in MRK in Q1 2016 and has held it in 4 quarters since. The position peaked at $149K in Q3 2016. 1,912 funds tracked by Wall St. Rank hold MRK as of Q4 2016.

  • Sunnymeath Asset Management held 1,897 shares of Merck worth $107K as of Q4 2016.
  • Sunnymeath Asset Management sold 3,144 Merck shares in Q4 2016, an estimated $184K.
  • Merck made up 0.15% of Sunnymeath Asset Management's portfolio in Q4 2016, its #84 holding.
  • Sunnymeath Asset Management first reported a position in Merck in Q1 2016 and has held it in 4 quarters since.
  • Sunnymeath Asset Management's Merck position peaked at $149K in Q3 2016.
  • 1,912 funds tracked by Wall St. Rank held Merck as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.